Will help lead firm’s global life sciences practice supporting
international pharmaceutical and medical device organizations
CHICAGO--(BUSINESS WIRE)--Apr. 2, 2019--
Life sciences and pharmaceutical professional Mark J. Stevens has joined
Navigant (NYSE: NCI) as a managing director in its life sciences
Stevens will help lead Navigant’s global life sciences strategy
consulting and data analytics team, and assist with creating centers of
excellence focusing on patient services, operations, and
pharmacovigilance. He brings more than 20 years of large and small
pharmaceutical company experience leading strategy, operations,
marketing, and sales analytics and technology.
According to Eduardo Schur, managing director and leader of Navigant’s
global life sciences practice, “The complexity of the global life
sciences market continues to accelerate. Mark will work with some of the
largest pharmaceutical and medical device organizations around the world
to build insightful and value-based solutions supporting planning,
strategy, and execution. We’re thrilled to have him on board.”
Stevens previously served as chief strategy officer at Publicis Health,
where he was responsible for the development and execution of strategic
initiatives in all program areas of Publicis Health Solutions. He also
served in multiple leadership roles in commercial effectiveness at
Novartis, Bristol Myers Squibb, Sanofi, and Schering Plough. Stevens
holds a Master of Science in management systems with specialization in
advanced analytics from Clarkson University, and an MBA with
specialization in marketing and a Bachelor of Science in biology from
University of Madras.
life sciences practice is comprised of specialized consultants,
former pharmaceutical and medical technology executives, clinicians, and
other experts with decades of strategy, operational consulting,
compliance, regulatory, and reimbursement services experience.
Professionals collaborate with life sciences clients, as well as
hospitals and health systems, physician enterprises, payers, and
government, to provide strategic management solutions. Navigant’s life
sciences practice is a part of the firm’s healthcare segment.
Navigant Consulting, Inc. (NYSE: NCI) is a specialized, global
professional services firm that helps clients take control of their
future. Navigant’s professionals apply deep industry knowledge,
substantive technical expertise, and an enterprising approach to help
clients build, manage, and/or protect their business interests. With a
focus on markets and clients facing transformational change and
significant regulatory or legal pressures, the firm primarily serves
clients in the healthcare, energy, and financial services industries.
Across a range of advisory, consulting, outsourcing, and
technology/analytics services, Navigant’s practitioners bring sharp
insight that pinpoints opportunities and delivers powerful results. More
information about Navigant can be found at navigant.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20190402005114/en/
Navigant Investor Relations